TXNRD2
Basic information
Region (hg38): 22:19875517-19941820
Links
Phenotypes
GenCC
Source:
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
- familial glucocorticoid deficiency (Supportive), mode of inheritance: AR
- dilated cardiomyopathy (Limited), mode of inheritance: AD
- glucocorticoid deficiency 5 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Glucocorticoid deficiency 5 | AR | Endocrine | Individuals have been described as having glucocorticoid deficiency, with poor cortisol response to ACTH stimulation, and required glucocorticoid replacement therapy | Endocrine | 24601690 |
ClinVar
This is a list of variants' phenotypes submitted to
- Primary_dilated_cardiomyopathy (561 variants)
- Cardiovascular_phenotype (443 variants)
- not_provided (179 variants)
- not_specified (48 variants)
- Glucocorticoid_deficiency_5 (32 variants)
- TXNRD2-related_disorder (27 variants)
- Primary_familial_hypertrophic_cardiomyopathy (6 variants)
- Tramadol_response (5 variants)
- Cardiomyopathy (1 variants)
- TXNRD2-associated_Cardiomyopathy (1 variants)
- Ependymoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXNRD2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006440.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 181 | 190 | ||||
| missense | 339 | 34 | 377 | |||
| nonsense | 9 | |||||
| start loss | 2 | 2 | ||||
| frameshift | 12 | 12 | ||||
| splice donor/acceptor (+/-2bp) | 21 | 21 | ||||
| Total | 0 | 1 | 387 | 215 | 8 |
Highest pathogenic variant AF is 0.000011632028
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TXNRD2 | protein_coding | protein_coding | ENST00000400521 | 17 | 66302 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.47e-11 | 0.742 | 124688 | 0 | 215 | 124903 | 0.000861 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.636 | 296 | 328 | 0.901 | 0.0000219 | 3308 |
| Missense in Polyphen | 120 | 140.22 | 0.85579 | 1370 | ||
| Synonymous | -0.601 | 146 | 137 | 1.07 | 0.00000976 | 1088 |
| Loss of Function | 1.60 | 21 | 30.5 | 0.687 | 0.00000159 | 336 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00116 | 0.00116 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000111 | 0.000111 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000541 | 0.000521 |
| Middle Eastern | 0.000111 | 0.000111 |
| South Asian | 0.00392 | 0.00393 |
| Other | 0.000827 | 0.000823 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the control of reactive oxygen species levels and the regulation of mitochondrial redox homeostasis (PubMed:24601690). Maintains thioredoxin in a reduced state. May play a role in redox-regulated cell signaling. {ECO:0000269|PubMed:24601690}.;
- Pathway
- Selenocompound metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Selenium Micronutrient Network;Selenium Metabolism and Selenoproteins;Oxidative Stress;Detoxification of Reactive Oxygen Species;Cellular responses to stress;Pyrimidine metabolism;Cellular responses to external stimuli;thioredoxin pathway
(Consensus)
Recessive Scores
- pRec
- 0.337
Intolerance Scores
- loftool
- 0.597
- rvis_EVS
- 0.63
- rvis_percentile_EVS
- 83.55
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.292
- ghis
- 0.470
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.995
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Txnrd2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; liver/biliary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- response to oxygen radical;electron transport chain;cellular response to oxidative stress;cell redox homeostasis;cellular oxidant detoxification
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- thioredoxin-disulfide reductase activity;protein binding;electron transfer activity;flavin adenine dinucleotide binding